Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)

NCT00687011 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

118

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms
Nausea
Vomiting

Interventions

DRUG: Palonosetron and Dexamethasone

Sponsor

Merck Sharp & Dohme LLC